# FDA recall D-1329-2020

> **BIOTA Biosciences LLC** · Class II · drug recall initiated 2020-05-11.

## Product

Sterile Cannabidiol (CBD) + Curcumin 50mg/mL, 10 mL vial

## Reason for recall

Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

## Distribution

Nationwide within the United States and New Zealand

## Key facts

- **Recall number:** D-1329-2020
- **Recalling firm:** BIOTA Biosciences LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-05-11
- **Report date:** 2020-07-01
- **Termination date:** 2020-12-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Seattle, WA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1329-2020

## Citation

> AI Analytics. FDA recall D-1329-2020. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1329-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*